Compile Data Set for Download or QSAR
maximum 50k data
Found 114 with Last Name = 'kawamura' and Initial = 't'
TargetProtein kinase C delta type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  87nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta-C1B domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C eta type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  360nMAssay Description:Inhibition of [3H]PDBu binding to PKCeta-C1B domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C epsilon type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  480nMAssay Description:Inhibition of [3H]PDBu binding to PKCepsilon-C1B domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C alpha type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  600nMAssay Description:Inhibition of [3H]PDBu binding to PKCalpha-C1A domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C gamma type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  660nMAssay Description:Inhibition of [3H]PDBu binding to PKCgamma-C1A domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C beta type(Homo sapiens (Human))
Keio University

Curated by ChEMBL
LigandPNGBDBM50348877(CHEMBL1807163)
Affinity DataKi:  730nMAssay Description:Inhibition of [3H]PDBu binding to PKCbeta-C1A domain peptideMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292221((S)-3-(2,4-Dichloro-phenyl)-1-(2-diethylamino-ethy...)
Affinity DataIC50:  0.0200nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447747(CHEMBL3113272)
Affinity DataIC50:  0.0250nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447748(CHEMBL3113271)
Affinity DataIC50:  0.0720nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447745(CHEMBL3113274)
Affinity DataIC50:  0.0800nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50366689(GHRELIN)
Affinity DataIC50:  0.140nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447747(CHEMBL3113272)
Affinity DataIC50:  0.170nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292225((S)-3-(2,5-Dichloro-phenyl)-1-(2-diethylamino-ethy...)
Affinity DataIC50:  0.240nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447746(CHEMBL3113273)
Affinity DataIC50:  0.280nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447745(CHEMBL3113274)
Affinity DataIC50:  0.340nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447749(CHEMBL3113270)
Affinity DataIC50:  0.430nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426652(CHEMBL2326178)
Affinity DataIC50:  0.430nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426652(CHEMBL2326178)
Affinity DataIC50:  0.460nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426651(CHEMBL2326194)
Affinity DataIC50:  0.670nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426650(CHEMBL2326177)
Affinity DataIC50:  0.710nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447746(CHEMBL3113273)
Affinity DataIC50:  0.720nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426651(CHEMBL2326194)
Affinity DataIC50:  0.75nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426648(CHEMBL2326197)
Affinity DataIC50:  0.800nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426650(CHEMBL2326177)
Affinity DataIC50:  0.860nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426649(CHEMBL2326192)
Affinity DataIC50:  0.920nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426649(CHEMBL2326192)
Affinity DataIC50:  0.960nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447749(CHEMBL3113270)
Affinity DataIC50:  1.10nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447748(CHEMBL3113271)
Affinity DataIC50:  1.20nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426647(CHEMBL2326196)
Affinity DataIC50:  1.20nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426645(CHEMBL2326193)
Affinity DataIC50:  1.20nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426648(CHEMBL2326197)
Affinity DataIC50:  1.30nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426646(CHEMBL2326189)
Affinity DataIC50:  1.30nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426647(CHEMBL2326196)
Affinity DataIC50:  1.40nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447750(CHEMBL3113269)
Affinity DataIC50:  1.5nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292228((S)-3-(2,3-Dichloro-phenyl)-1-(2-diethylamino-ethy...)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426646(CHEMBL2326189)
Affinity DataIC50:  1.70nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447750(CHEMBL3113269)
Affinity DataIC50:  1.70nMAssay Description:Apparent inhibition of rat FAAH using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426644(CHEMBL2326195)
Affinity DataIC50:  2nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426645(CHEMBL2326193)
Affinity DataIC50:  2.10nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50151162((S)-3-(2-Chloro-phenyl)-1-(2-diethylamino-ethyl)-3...)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50447751(CHEMBL3113268)
Affinity DataIC50:  2.20nMAssay Description:Apparent inhibition of human FAAH expressed in CHOK1 cells using AMCAA as substrate after 30 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50244993(4-(3-phenyl-1,2,4-thiadiazol-5-yl)-N-(pyridin-3-yl...)
Affinity DataIC50:  2.40nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426643(CHEMBL2326190)
Affinity DataIC50:  2.90nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426644(CHEMBL2326195)
Affinity DataIC50:  3.20nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426643(CHEMBL2326190)
Affinity DataIC50:  3.30nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50426641(CHEMBL2326181)
Affinity DataIC50:  3.70nMAssay Description:Apparent inhibition of human FAAH expressed in CHO-K1 cells using ethanolamine 1-3[H] as substrate after 30 mins by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFatty-acid amide hydrolase 1 [30-579](Rattus norvegicus (rat))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50244993(4-(3-phenyl-1,2,4-thiadiazol-5-yl)-N-(pyridin-3-yl...)
Affinity DataIC50:  3.80nMAssay Description:Apparent inhibition of rat FAAH after 30 minsMore data for this Ligand-Target Pair
TargetFatty-acid amide hydrolase 1(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM26739(3-(3-carbamoylphenyl)phenyl N-cyclohexylcarbamate ...)
Affinity DataIC50:  4nMAssay Description:Inhibition of FAAH (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50151162((S)-3-(2-Chloro-phenyl)-1-(2-diethylamino-ethyl)-3...)
Affinity DataIC50:  4nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Sumitomo Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292230((S)-3-(2,6-Dichloro-phenyl)-1-(2-diethylamino-ethy...)
Affinity DataIC50:  4.20nMAssay Description:Inhibition of [125I]ghrelin binding to human recombinant ghrelin receptor membrane preparationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 114 total ) | Next | Last >>
Jump to: